SecurityHDNG / Hardinge, Inc. (412324303)
Institutional Owners94 (7 N-Q Owners)
Institutional Shares11,008,270 - 84.90% (ex. N-Q)
Common Shares Outstanding12,966,148 shares (as of 2017-12-31)
Institutional Value$ 204,608,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Hardinge, Inc. (NASDAQ:HDNG) has 94 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,008,270 shares. Largest shareholders include Privet Fund LP, Dimensional Fund Advisors Lp, Kennedy Capital Management, Inc., BlackRock Inc., Wellington Trust Co NA, Vanguard Group Inc, Wellington Management Group LLP, First Wilshire Securities Management Inc, Renaissance Technologies LLC, and Franklin Resources Inc.
Hardinge, Inc. (NASDAQ:HDNG) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR A.R.T. Advisors, LLC 0 13,525 0 247
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 0 22,474 0 412
2018-02-12 13F-HR AMERIPRISE FINANCIAL INC 137,162 0 -100.00 2,094 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 97,003 137,637 41.89 1,688 2,520 49.29
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 736 13
2018-05-04 13F-HR SHUFRO ROSE & CO LLC 35,200 22,900 -34.94 613 420 -31.48
2018-04-25 SC 13D/A Privet Fund LP 1,373,820 1,373,820 0.00
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 7,791 7,393 -5.11 136 135 -0.74
2018-05-15 13F-HR PEAK6 Investments, L.P. Put 3,500 64
2018-05-11 13F-HR Cutler Group LP 5,213 0 -100.00 90 0 -100.00
2018-05-15 13F-HR GAM Holding AG 184,400 3,378
2018-05-11 13F-HR Pacific Ridge Capital Partners, LLC 313,289 210,159 -32.92 5,457 3,850 -29.45
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 27,069 20,339 -24.86 471 373 -20.81
2018-05-08 13F-HR Alambic Investment Management, L.P. 80,239 193,738 141.45 1,398 3,549 153.86
2018-05-14 13F-HR Stone Ridge Asset Management LLC 36,791 37,644 2.32 641 690 7.64
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 1,777 1,854 4.33 31 34 9.68
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 6,927 18,883 172.60 121 346 185.95
2018-04-09 SC 13G/A Royce & Associates LLC 1,048,554 141,484 -86.51
2018-05-10 13F-HR JP Morgan Chase & Co 22,059 2,328 -89.45 384 43 -88.80
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 3,275 2,335 -28.70 57,050 42,777 -25.02
2018-02-15 13F-HR GLENMEDE TRUST CO NA 4,000 0 -100.00 61 0 -100.00
2018-05-08 13F-HR US BANCORP \DE\ 93,320 60,873 -34.77 1,627 1,115 -31.47
2018-05-14 13F-HR Walthausen & Co., LLC 32,200 23,951 -25.62 561 439 -21.75
2018-04-24 13F-HR McAdam, LLC 157 3
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,318 17,614 -3.84 319 323 1.25
2018-05-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 467,972 1,049,414 124.25 8,152 19,225 135.83
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 500 9
2018-05-14 13F-HR EAM Investors, LLC 48,561 0 -100.00 846 0 -100.00
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 53,750 58,207 8.29 936 1,066 13.89
2018-05-22 13F-HR/A Summit Trail Advisors, Llc 19 0 -100.00 0 0
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 41,312 1,094 -97.35 720 20 -97.22
2018-02-28 N-Q Ishares Trust (see advisory)
2018-05-18 N-Q State Farm Variable Product Trust (see advisory)
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 10,753 9,792 -8.94 187 179 -4.28
2018-05-09 13F-HR BlackRock Inc. 842,897 844,548 0.20 14,684 15,473 5.37
2018-05-11 13F-HR SEI INVESTMENTS CO 248 240 -3.23 4 4 0.00
2018-04-20 13F-HR STRS OHIO 38,300 37,200 -2.87 667 681 2.10
2018-05-09 13F-HR NORTHERN TRUST CORP 140,226 147,113 4.91 2,443 2,695 10.32
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 219 219 0.00 4 4 0.00
2018-05-08 13F-HR ClariVest Asset Management LLC 19,890 0 -100.00 346 0 -100.00
2018-02-15 13F-HR Fieldpoint Private Securities, LLC 1,699 0 -100.00 26 0 -100.00
2018-05-18 N-Q State Farm Mutual Fund Trust (see advisory)
2018-05-25 N-Q Great-west Funds Inc (see advisory)
2018-04-26 13F-HR RUTABAGA CAPITAL MANAGEMENT LLC/MA 72,010 71,010 -1.39 1,254 1,301 3.75
2018-05-08 13F-HR Kassirer Asset Management Corp 111,939 2,051
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 20,804 381
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 1,089,125 1,092,855 0.34 18,973 20,021 5.52
2018-05-15 13F-HR CAPSTONE INVESTMENT ADVISORS, LLC 24,020 440
2018-05-09 13F-HR Mint Tower Capital Management B.V. 25,000 458
2018-02-09 13F-HR Alexandria Capital, LLC 3,415 0 -100.00 52 0 -100.00
2018-02-13 13F-HR OXFORD ASSET MANAGEMENT 41,387 0 -100.00 639 0 -100.00
2018-05-15 13F-HR LUCUS ADVISORS LLC 12,362 226
2018-05-15 13F-HR Invesco Ltd. 0 27,332 0 500
2018-05-15 13F-HR HIGHLAND CAPITAL MANAGEMENT LP 32,900 122,500 272.34 573 2,244 291.62
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 11,900 36,658 208.05 207 672 224.64
2018-02-13 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 16,362 0 -100.00 250 0 -100.00
2018-05-10 13F-HR Spark Investment Management LLC 30,200 81,200 168.87 526 1,487 182.70
2018-05-15 13F-HR UBS Group AG 570 423 -25.79 10 8 -20.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 19,705 19,705 0.00 343 361 5.25
2018-02-08 SC 13G Wellington Trust Co NA 655,575
2018-05-02 13F-HR ALGERT GLOBAL LLC 209,894 222,910 6.20 3,656 4,084 11.71
2018-05-16 13F-HR Foundry Partners, LLC 190,980 0 -100.00 3,327 0 -100.00
2018-04-19 13F-HR JOHN G ULLMAN & ASSOCIATES INC 178,837 87,341 -51.16 3,115 1,600 -48.64
2018-03-29 N-Q Advisors' Inner Circle Fund (see advisory)
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 0 150,048 0 2,749
2018-05-15 13F-HR BlueCrest Capital Management Ltd 24,477 448
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 911 911 0.00 16 17 6.25
2018-05-09 13F-HR GABELLI SECURITIES, INC. 18,900 346
2018-04-25 13F-HR Bowling Portfolio Management LLC 104,013 1,906
2018-02-13 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 13,812 0 -100.00 211 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC 0 3,198 0 58
2018-05-15 13F-HR PERRITT CAPITAL MANAGEMENT INC 51,095 0 -100.00 890 0 -100.00
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 15 81 440.00 0 1
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 15,600 0 -100.00 272 0 -100.00
2018-05-16 SC 13E3/A Hardinge Inc
2018-05-15 13F-HR Brandywine Global Investment Management, LLC 9,234 0 -100.00 161 0 -100.00
2018-05-15 13F-HR RBF Capital, LLC 70,000 0 -100.00 1,219 0 -100.00
2018-05-04 13F-HR MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 66,868 0 -100.00 1,164,841 0 -100.00
2018-05-07 13F-HR BAILARD, INC. 36,900 30,800 -16.53 643 564 -12.29
2018-05-11 13F-HR CITIGROUP INC 9,555 7,737 -19.03 167 141 -15.57
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 46,866 43,826 -6.49 816 803 -1.59
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1,806 755 -58.19 31 14 -54.84
2018-04-26 13F-HR GRACE & WHITE INC /NY 237,174 222,605 -6.14 4,132 4,078 -1.31
2018-05-14 13F-HR MORGAN STANLEY 93,483 101,039 8.08 1,628 1,852 13.76
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 83,393 99,107 18.84 1,452 1,815 25.00
2018-05-15 13F-HR Venator Capital Management Ltd. 155,071 0 -100.00 2,701 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 5,063 9,029 78.33 89 166 86.52
2018-05-03 13F-HR SG Americas Securities, LLC 0 74,051 0 1,357
2018-05-09 13F-HR GABELLI FUNDS LLC 11,771 216
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 30,684 28,531 -7.02 535 523 -2.24
2018-05-02 13F-HR HARVEST MANAGEMENT LLC 40,000 733
2018-05-15 13F-HR VANGUARD GROUP INC 466,986 523,377 12.08 8,135 9,589 17.87
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 2,400 1,300 -45.83 35 22 -37.14
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 87,610 27,900 -68.15 1,527 512 -66.47
2018-05-10 13F-HR Municipal Employees' Retirement System of Michigan 25,560 0 -100.00 445 0 -100.00
2018-05-15 13F-HR FIRST WILSHIRE SECURITIES MANAGEMENT INC 331,822 323,547 -2.49 5,780 5,927 2.54
2018-02-01 13F-HR Nationwide Fund Advisors 9,807 0 -100.00 150 0 -100.00
2018-02-14 13F-HR PDT Partners, LLC 10,500 0 -100.00 160 0 -100.00
2018-05-02 13F-HR DUPONT CAPITAL MANAGEMENT Corp 71,000 1,301
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 234,800 234,600 -0.09 4,090 4,298 5.09
2018-05-15 13F-HR STATE STREET CORP 167,671 177,389 5.80 2,920 3,250 11.30
2018-04-18 13F-HR FNY Managed Accounts LLC 114 2
2018-05-15 13F-HR Beryl Capital Management Llc 74,654 1,368
2018-05-11 13F-HR Russell Investments Group, Ltd. 8,380 25,392 203.01 145 465 220.69
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 19,250 19,250 0.00 335 353 5.37
2018-05-10 13F-HR FRANKLIN RESOURCES INC 502,600 312,300 -37.86 8,755 5,721 -34.65
2018-05-17 13F-HR Legal & General Group Plc 2,022 2,022 0.00 35 37 5.71
2018-02-14 13F-HR NUMERIC INVESTORS LLC 0 25,261 0 440
2018-05-15 13F-HR PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 32,392 593
2018-04-02 13F-HR KSA CAPITAL MANAGEMENT, LLC 20,800 0 -100.00 362 0 -100.00
2018-05-11 13F-HR Cutler Group LP Call 1,300 0 -100.00 0 0
2018-05-15 13F-HR PEAK6 Investments, L.P. 0 66,605 0 1,220
2018-01-18 13F-HR ACADIAN ASSET MANAGEMENT LLC 228,480 0 -100.00 3,490 0 -100.00
2018-03-29 N-Q Franklin Value Investors Trust (see advisory)
2018-02-14 13F-HR AEGIS FINANCIAL CORP 65,678 0 -100.00 1,003 0 -100.00
2018-04-20 13F-HR FIRST MANHATTAN CO 36,950 36,950 0.00 643 676 5.13
2018-05-15 13F-HR Bank of New York Mellon Corp 58,040 74,001 27.50 1,011 1,356 34.12
2018-04-30 13F-HR REILLY FINANCIAL ADVISORS, LLC 58 1
2018-03-27 N-Q PRINCIPAL FUNDS INC (see advisory)
2018-05-14 13F-HR Renaissance Technologies LLC 331,000 323,300 -2.33 5,766 5,923 2.72
2018-05-15 13F-HR Wellington Management Group LLP 659,488 421,083 -36.15 11,488 7,714 -32.85
2018-05-02 13F-HR RHUMBLINE ADVISERS 0 11,191 0 205

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( HDNG / Hardinge, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

Related News Stories

Hurco Off To A Strong Start

2018-03-12 seekingalpha
Hurco outgrew the underlying machine tool markets in its core footprint and posted over 30% growth in revenue and nearly 20% growth in orders. (1-0)

Hardinge Should Stay Public

2018-03-02 seekingalpha
The termination fees seem high. In our opinion, the parties are trying to block a potential deal with another player. (1-0)

The Ideal Stock Evaluation System?

2018-01-22 seekingalpha
About two and a half years ago, I had a revelation. I’d been losing money for years, choosing the wrong stocks, buying and selling them at the wrong times. But I suddenly realized that the key to success in the stock market is not just screening stocks on a few factors but instead to systematically evaluate every stock from as many angles as possible before buying it. Since I put my initial evaluation system in place around Halloween 2015, my compound annual returns have been 47%--a total growth of 135% in 27 months. (209-4)

Hurco Rebounding With The Machine Tool Cycle

2018-01-08 seekingalpha
Hurco reported double-digit revenue growth in the fourth quarter and high single-digit order growth as manufacturing demand continues to improve, and particularly in Germany. (1-0)

CUSIP: 412324303